Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Mercer Global Advisors Inc. ADV

Mercer Global Advisors Inc. ADV boosted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 6.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,969 shares of the company’s stock after purchasing an additional 374 shares during the quarter. Mercer Global Advisors Inc. ADV’s holdings in Prestige Consumer Healthcare were worth $411,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in Prestige Consumer Healthcare during the fourth quarter worth about $27,739,000. UBS Group AG boosted its position in shares of Prestige Consumer Healthcare by 377.6% in the fourth quarter. UBS Group AG now owns 131,382 shares of the company’s stock valued at $8,043,000 after acquiring an additional 103,872 shares during the period. Franklin Resources Inc. raised its stake in shares of Prestige Consumer Healthcare by 9.6% in the fourth quarter. Franklin Resources Inc. now owns 20,057 shares of the company’s stock valued at $1,228,000 after purchasing an additional 1,764 shares in the last quarter. Hsbc Holdings PLC raised its stake in shares of Prestige Consumer Healthcare by 8.9% in the fourth quarter. Hsbc Holdings PLC now owns 24,050 shares of the company’s stock valued at $1,469,000 after purchasing an additional 1,975 shares in the last quarter. Finally, Parallel Advisors LLC raised its stake in Prestige Consumer Healthcare by 42.5% during the fourth quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock worth $44,000 after acquiring an additional 213 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Trading Down 0.0 %

Shares of PBH opened at $71.32 on Friday. The business’s 50-day moving average price is $71.21 and its 200-day moving average price is $69.63. Prestige Consumer Healthcare Inc. has a twelve month low of $56.34 and a twelve month high of $75.80. The stock has a market cap of $3.53 billion, a PE ratio of 17.10, a P/E/G ratio of 2.01 and a beta of 0.48. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. The company had revenue of $267.10 million during the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The firm’s revenue was down 4.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.06 earnings per share. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on PBH. DA Davidson raised their target price on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.